Form 6-K BioNTech SE For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
BioNTech (BNTX) PT Raised to $126 at BMO Capital
November 4, 2024 4:06 PM ESTBMO Capital analyst Etzer Darout raised the price target on BioNTech (NASDAQ: BNTX) to $126.00 (from $122.00) while maintaining a Outperform rating.
The analyst comments "BNTX announced revenues of 1.24B, above FactSet consensus (+142%) and reiterated FY24 guidance of 2.5-3.1B in revenues,... More
BofA Securities Reiterates Buy Rating on BioNTech (BNTX)
November 4, 2024 12:47 PM ESTBofA Securities analyst Tazeen Ahmad reiterated a Buy rating and $150.00 price target on BioNTech (NASDAQ: BNTX).
The analyst comments "BioNTech (BNTX) reported 1.2bn in 3Q COVID revenues ahead of our and consensus 362mn estimates. The company noted this was mainly driven by earlier global... More
